About
Yumanity is a biopharmaceutical company specifically focused on discovering and developing innovative novel therapies to treat devastating neurodegenerative diseases with a critical unmet need. Target conditions include large or orphan disease markets, such as Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, or MSA, amyotrophic lateral sclerosis, or ALS, and frontotemporal lobar dementia, or FTLD.